111 related articles for article (PubMed ID: 20541667)
1. Pathogenesis of pituitary tumors.
Yu R; Melmed S
Prog Brain Res; 2010; 182():207-27. PubMed ID: 20541667
[TBL] [Abstract][Full Text] [Related]
2. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of pituitary adenomas.
Donangelo I; Melmed S
J Endocrinol Invest; 2005; 28(11 Suppl International):100-5. PubMed ID: 16625857
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.
Wierinckx A; Auger C; Devauchelle P; Reynaud A; Chevallier P; Jan M; Perrin G; Fèvre-Montange M; Rey C; Figarella-Branger D; Raverot G; Belin MF; Lachuer J; Trouillas J
Endocr Relat Cancer; 2007 Sep; 14(3):887-900. PubMed ID: 17914117
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.
Salehi F; Kovacs K; Scheithauer BW; Lloyd RV; Cusimano M
Endocr Relat Cancer; 2008 Sep; 15(3):721-43. PubMed ID: 18753362
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
11. [Rol of pituitary tumour-transforming gene (PTTG) in the pituitary adenomas].
Sánchez-Ortiga R; Sánchez Tejada L; Peiró Cabrera G; Moreno-Pérez O; Arias Mendoza N; Aranda López FI; Picó Alfonso A
Endocrinol Nutr; 2010 Jan; 57(1):28-34. PubMed ID: 20172484
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumour-transforming gene (PTTG) and pituitary senescence.
Chesnokova V; Melmed S
Horm Res; 2009 Apr; 71 Suppl 2():82-7. PubMed ID: 19407503
[TBL] [Abstract][Full Text] [Related]
13. Transgenic and knockout mouse models clarify pituitary development, function and disease.
Asa SL
Brain Pathol; 2001 Jul; 11(3):371-84. PubMed ID: 11414478
[TBL] [Abstract][Full Text] [Related]
14. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas.
Chamaon K; Kanakis D; Mawrin C; Dietzmann K; Kirches E
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):121-6. PubMed ID: 19472104
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of the P16INK4a gene product in human pituitary tumors.
Woloschak M; Yu A; Xiao J; Post KD
Cancer Res; 1996 Jun; 56(11):2493-6. PubMed ID: 8653683
[TBL] [Abstract][Full Text] [Related]
16. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
17. Oncogenesis and mutagenesis of pituitary tumors.
Sonabend AM; Musleh W; Lesniak MS
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S3-14. PubMed ID: 17004855
[TBL] [Abstract][Full Text] [Related]
18. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms Underlying Pituitary Pathogenesis.
Sapochnik M; Nieto LE; Fuertes M; Arzt E
Biochem Genet; 2016 Apr; 54(2):107-19. PubMed ID: 26718581
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
